Interference in melanoma CD248 function reduces vascular mimicry and metastasis

Area of Science:

• Oncology
• Cell Biology
• Cancer Research

Background:

• Tumor vascular mimicry is a critical factor in patient survival with no current treatments.
• Stromal factors influencing the tumor microenvironment and malignant transformation are not well understood.
• CD248, a transmembrane protein in stromal cells, interacts with extracellular matrix and is linked to melanoma metastasis.

Purpose of the Study:

• To investigate the cell-autonomous role of CD248 in melanoma vascular mimicry.
• To explore CD248's impact on melanoma cell adhesion, migration, and proliferation.
• To assess the therapeutic potential of targeting CD248 in melanoma.

Main Methods:

• Loss-of-function studies using B16F10 melanoma cells to assess CD248 effects.
• Solid-phase binding assays to determine CD248-fibronectin interaction.
• In vitro and in vivo experiments using recombinant CD248 (rCD248) in a mouse model of melanoma lung metastasis.

Main Results:

• CD248 knockdown reduced melanoma cell adhesion to fibronectin, migration, and vascular mimicry.
• The lectin domain of CD248 is crucial for fibronectin interaction.
• rCD248 inhibited melanoma cell adhesion and migration, and reduced lung metastasis and vascular mimicry in vivo.

Conclusions:

• CD248 expression in melanoma cells drives malignant transformation through increased adhesion, migration, and vascular mimicry.
• rCD248 protein acts as a molecular decoy, counteracting CD248's pro-tumorigenic functions in melanoma.
• Targeting CD248 offers a potential therapeutic strategy for melanoma treatment.